Clearpoint Neuro Inc (CLPT)

$9.60 -1.56 (-13.98%)
Market Cap 317.20M
Revenue (ttm) 31.39M
Net Income (ttm) -18.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60.24%
Debt to Equity Ratio 1.84
Volume 1,520,200
Avg Vol 862,214
Day's Range N/A - N/A
Shares Out 28.42M
Stochastic %K 23%
Beta 1.02
Analysts Strong Sell
Price Target $24.00

Company Profile

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration a...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 287 9109
Address:
120 S. Sierra Avenue, Suite 100, Solana Beach, United States
InfernoWyrm
InfernoWyrm Mar. 18 at 11:52 PM
$DFLI $QFIN $LWLG $CLPT tttttt
0 · Reply
erevnon
erevnon Mar. 18 at 6:47 PM
B. Riley Securities maintains ClearPoint Neuro $CLPT at Buy and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Thinkingman91
Thinkingman91 Mar. 18 at 3:51 PM
$CLPT offering? Run it first
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 18 at 3:48 PM
$CLPT
0 · Reply
lancergg
lancergg Mar. 18 at 3:40 PM
$CLPT Trash ass company
0 · Reply
Twister8
Twister8 Mar. 18 at 2:31 PM
$CLPT the company is getting buried in debt, they don't have the sales to back it...tic toc
0 · Reply
Twister8
Twister8 Mar. 18 at 2:30 PM
$CLPT spaghetti anyone?
0 · Reply
Twister8
Twister8 Mar. 18 at 2:05 PM
$CLPT baggies could have got out on the QURE news at 13-14…instead they chose to buy more at those prices…
0 · Reply
Twister8
Twister8 Mar. 18 at 1:59 PM
$CLPT
0 · Reply
Twister8
Twister8 Mar. 18 at 1:50 PM
$CLPT pump and dump the small niche wannabe…
0 · Reply
Latest News on CLPT
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

Mar 17, 2026, 7:42 PM EDT - 1 day ago

ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Mar 17, 2026, 4:05 PM EDT - 1 day ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

Mar 6, 2026, 8:00 AM EST - 12 days ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

ClearPoint Neuro: From Validation To Scale

Jan 27, 2026, 4:47 AM EST - 7 weeks ago

ClearPoint Neuro: From Validation To Scale

ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software

Jan 23, 2026, 11:16 AM EST - 7 weeks ago

ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

Jan 22, 2026, 4:30 PM EST - 7 weeks ago

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Jan 12, 2026, 8:30 AM EST - 2 months ago

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

ClearPoint Neuro Completes Acquisition of IRRAS

Nov 20, 2025, 5:00 PM EST - 4 months ago

ClearPoint Neuro Completes Acquisition of IRRAS

ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 5:21 PM EST - 4 months ago

ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript

ClearPoint Neuro: CRO Facility Should Reaccelerate Growth

Nov 12, 2025, 3:55 PM EST - 4 months ago

ClearPoint Neuro: CRO Facility Should Reaccelerate Growth

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:55 PM EST - 4 months ago

ClearPoint Neuro Reports Third Quarter 2025 Results

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 6, 2025, 4:50 PM EST - 4 months ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Nov 5, 2025, 5:02 PM EST - 4 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 7, 2025, 4:15 PM EDT - 5 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 6, 2025, 4:10 PM EDT - 5 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

ClearPoint Neuro: AMT-130 Highlights A Bright Future

Oct 2, 2025, 5:05 PM EDT - 5 months ago

ClearPoint Neuro: AMT-130 Highlights A Bright Future

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Oct 1, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

ClearPoint Neuro: Selling The Tools For Brain Therapies

Sep 25, 2025, 5:50 PM EDT - 6 months ago

ClearPoint Neuro: Selling The Tools For Brain Therapies

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 25, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Sep 4, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

ClearPoint Neuro: Biopharma Momentum Continues To Build

Aug 14, 2025, 10:22 PM EDT - 7 months ago

ClearPoint Neuro: Biopharma Momentum Continues To Build

ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 10:31 PM EDT - 7 months ago

ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 12, 2025, 4:05 PM EDT - 7 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Aug 4, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

Jul 23, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

ClearPoint Neuro: Consumables Growth Is Promising

Jun 27, 2025, 5:46 PM EDT - 9 months ago

ClearPoint Neuro: Consumables Growth Is Promising

I Missed The Quantum Rally - I Won't Miss The Next One

May 20, 2025, 5:47 AM EDT - 10 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR EDIT NTLA VANI VERV

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:02 PM EDT - 11 months ago

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

ClearPoint Neuro Reports First Quarter 2025 Results

May 13, 2025, 4:40 PM EDT - 11 months ago

ClearPoint Neuro Reports First Quarter 2025 Results

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

May 12, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

ClearPoint Neuro: Fundamentals Continue To Strengthen

Apr 29, 2025, 12:00 AM EDT - 11 months ago

ClearPoint Neuro: Fundamentals Continue To Strengthen

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 28, 2025, 8:00 AM EDT - 11 months ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 25, 2025, 8:00 AM EDT - 11 months ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Apr 24, 2025, 8:00 AM EDT - 11 months ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

Feb 27, 2025, 11:18 PM EST - 1 year ago

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 7:17 PM EST - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 14, 2025, 8:00 AM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Feb 12, 2025, 4:15 PM EST - 1 year ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Jan 27, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

ClearPoint Neuro: Near-Term Volatility Is No Concern

Nov 10, 2024, 9:35 AM EST - 1 year ago

ClearPoint Neuro: Near-Term Volatility Is No Concern

ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:31 PM EST - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript

ClearPoint Neuro Reports Third Quarter 2024 Results

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 26, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade)

Aug 14, 2024, 9:33 AM EDT - 1 year ago

ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade)

ClearPoint Neuro: My Favorite Growth Stock

Aug 8, 2024, 7:39 PM EDT - 1 year ago

ClearPoint Neuro: My Favorite Growth Stock

ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:25 AM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript

InfernoWyrm
InfernoWyrm Mar. 18 at 11:52 PM
$DFLI $QFIN $LWLG $CLPT tttttt
0 · Reply
erevnon
erevnon Mar. 18 at 6:47 PM
B. Riley Securities maintains ClearPoint Neuro $CLPT at Buy and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Thinkingman91
Thinkingman91 Mar. 18 at 3:51 PM
$CLPT offering? Run it first
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 18 at 3:48 PM
$CLPT
0 · Reply
lancergg
lancergg Mar. 18 at 3:40 PM
$CLPT Trash ass company
0 · Reply
Twister8
Twister8 Mar. 18 at 2:31 PM
$CLPT the company is getting buried in debt, they don't have the sales to back it...tic toc
0 · Reply
Twister8
Twister8 Mar. 18 at 2:30 PM
$CLPT spaghetti anyone?
0 · Reply
Twister8
Twister8 Mar. 18 at 2:05 PM
$CLPT baggies could have got out on the QURE news at 13-14…instead they chose to buy more at those prices…
0 · Reply
Twister8
Twister8 Mar. 18 at 1:59 PM
$CLPT
0 · Reply
Twister8
Twister8 Mar. 18 at 1:50 PM
$CLPT pump and dump the small niche wannabe…
0 · Reply
Twister8
Twister8 Mar. 18 at 1:43 PM
$CLPT but but but, the shots on goal… spaghetti anyone?
0 · Reply
NY2CHI
NY2CHI Mar. 18 at 1:16 PM
$CLPT another partner showing great data on Parkinson outcomes, preparing for phase 3 later this year. https://www.prnewswire.com/news-releases/aspen-neuroscience-announces-positive-12month-data-from-its-aspiro-clinical-trial-in-a-latebreaking-oral-presentation-at-the-adpd-2026-international-conference-on-alzheimers-and-parkinsons-diseases-302716505.html
1 · Reply
capntrps
capntrps Mar. 18 at 12:56 PM
$CLPT at a 30% growth rate from m8dpoint of 2026 revenues gives you $118MIL by 2029. Guess I shouldnt be that impressed by that, or they need a catalyst to grow faster. 2029 revenue would be approx 3x sales, and maybe this industry could justify 6x sales. So(with this estimate). A double in three years if no dillution, plus 30% growth after that for a while. Best scenario is a catalyst to accelerate growth from here, reduce risk of dilution and increase valuation(pull forward).
0 · Reply
capntrps
capntrps Mar. 17 at 11:24 PM
$CLPT lowered the revenue midpoint which i dont like. I have modeled out 25% growth from 56mil in 2026. Now they need higher growth. Shocked they never get a bump in revs or trend growth, but they dont/havent.
0 · Reply
Twister8
Twister8 Mar. 17 at 10:30 PM
$CLPT Joe checking his emails for partner updates with fda…
0 · Reply
Twister8
Twister8 Mar. 17 at 9:52 PM
$CLPT weak
0 · Reply
WonderfulMongoose
WonderfulMongoose Mar. 17 at 9:11 PM
$CLPT guiding for 40% YoY revenue growth.
2 · Reply
yumkatel
yumkatel Mar. 17 at 9:06 PM
$CLPT 9$ tomorrow
0 · Reply
NY2CHI
NY2CHI Mar. 17 at 8:35 PM
$CLPT FDA fast tracked partner progression.
0 · Reply
NY2CHI
NY2CHI Mar. 17 at 8:29 PM
$CLPT shots on goal.
0 · Reply
StockNews_Live
StockNews_Live Mar. 17 at 8:17 PM
$CLPT 🎯 STOCK NEWS ALERT 💵 Price: $11.30 (+2.67%) 🔥 Sentiment Score: 92/100 🚀 VERY POSITIVE NEWS 📄 ClearPoint Neuro, Inc. reported fourth quarter revenue of $10.4 million, representing 34% overall growth and 19% year-over-year organic growth compared with the fourth quarter of 2024. The company… 📎 https://stocknews.live/news/CLPT/clear-point-neuro-reports-fourth-quarter-and-full-year-2025-uztz9gnsccjk.html
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 17 at 8:16 PM
$CLPT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.27 down -35.00% YoY • Reported revenue of $10.41M up 33.96% YoY • ClearPoint Neuro expects 2026 revenues to range between $52M and $56M, as the company continues to support biopharma partners and enters its "Essential. Everywhere." phase.
0 · Reply